CBD-Intel has compiled and classified the regulatory data on medical and recreational cannabis in 50 jurisdictions around the world.
The following report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries using maps, and assesses the likelihood that the status quo may change in the future.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
Table of contents